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Review Article

Cardiac interventions in patients with achondroplasia: a
systematic review
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Abstract: Patients with achondroplasia and other causes of dwarfism suffer from increased rates of
cardiovascular disease relative to the remainder of the population. Few studies have examined these patients
when undergoing cardiac surgery or percutaneous intervention. This systematic review examines the
literature to determine outcomes following cardiac intervention in this unique population. An electronic
search was performed in the English literature to identify all reports of achondroplasia, dwarfism, and
cardiac intervention. Of the 5,274 articles identified, 14 articles with 14 cases met inclusion criteria. Patientlevel data was extracted and analyzed. Median patient age was 55.5 [interquartile ranges (IQR), 43.8, 59.8]
years, median height 102.0 [98.8, 112.5] cm, median BMI 32.1 [27.0, 45.9], and 57.1% (8/14) were male.
Of these 14 patients, nine had the following documented skeletal abnormalities: 66.7% (6/9) had scoliosis,
66.7% (6/9) had kyphosis, 11.1% (1/9) had lordosis, 11.1% (1/9) pectus carinatum and 11.1% (1/9) spinal
stenosis. Coronary artery disease was present in 53.8% (7/13), and 30.8% (4/13) patients previously suffered
a myocardial infarction. Of the eight patients who underwent cardiac surgery, 37.5% (3/8) underwent
multivessel coronary artery bypass grafting, 37.5% (3/8) underwent aortic valve replacement, 25.0%
(2/8) underwent type A aortic dissection repair, and the remaining 12.5% (1/8) underwent pulmonary
thromboendarterectomy. Six patients underwent percutaneous intervention. Median cardiopulmonary
bypass time was 136.5 [110.0, 178.8] minutes. Median arterial cannula size was 20.0 [20.0, 24.0] Fr. Bicaval
cannulation was performed in all cases describing cannulation strategy (5/5). Median superior vena cava
cannula size was 28.0 [28.0, 28.0] Fr, and inferior vena cava cannula size was 28.0 [28.0, 28.0] Fr. No
mortality was reported with a median follow up time of 6.0 [6.0, 10.5] months. In conclusion, Common
cardiac procedures can be performed with reasonable safety in this patient population. Operative adjustments
may need to be made with respect to equipment to accommodate patient-specific needs.
Keywords: Achondroplasia; dwarfism; outcomes; cardiac surgery; cardiac intervention
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Introduction
Achondroplasia and other causes of dwarfism represent a
minority of the overall population but only have slightly
shorter mean lifespans than non-dwarfs, 61 versus
71 years (1-3). With fairly long life spans, dwarfs are likely
to suffer from similar comorbidities as that of aging general
population. This population represents 0.36 to 0.60 per
10,000 live births, a minority group, but one that must
be considered with respect to interventions that may be
required of all aging groups (3). In particular, dwarfs have
an increased risk for cardiovascular disease and heartdisease related deaths. Between the ages of 25 to 35, dwarfs
have a tenfold increase in risk of mortality from heartrelated disease (4). This has been hypothesized to be due
to a propensity for arterial occlusion of narrower vessels
due to atherosclerosis in individuals of shorter stature (2).
Since this population has an increased risk of cardiovascular
disease, there is increased likelihood that dwarfs may
require percutaneous or invasive intervention to mitigate
atherosclerotic disease. This study examines a series of
case reports that have noted cardiac interventions in this
patient population and evaluates their safety, efficacy, and
outcomes.
While there are multiple causes of dwarfism,
achondroplasia is the most prevalent, accounting for more
than 90% of short stature individuals (5). It is inherited in an
autosomal-dominant fashion, and is fully penetrant. Despite
this inheritance pattern, 90% of cases are sporadic and
due to mutations in G1138A or G1138C in the fibroblast
growth factor 3 gene on chromosome 4p16.3 (5). This
results in a skeletal dysplasia with small stature, short limbs
with rhizomelic proportions, macrocephaly, a small chest,
thoracolumbar kyphosis, and lumbar hyperlordosis (5).
These anatomic variations can profoundly affect a patient’s
life but also must be understood by the clinician as
procedures will need to be tailored to the patient in order to
be successful.
Given these anatomic variations, Dwarfism has been
noted to be challenging for multiple medical providers
including the anesthetic clinician (6-8). As this population
ages, clinicians will need to be prepared to provide necessary
procedures to these individuals. Due to the increased
cardiovascular risks and a near normal life expectancy, it is
possible that people with dwarfism will need to undergo
cardiac intervention.
This systematic review examines 14 cases of patients
with achondroplasia undergoing cardiac procedures. As far
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as the authors know, these are the only cases documented
in the English medical literature noting individuals with
achondroplasia undergoing cardiac intervention. By pooling
this data, we hope to evaluate the safety and efficacy of
these procedures, especially with the knowledge that this
population is particularly vulnerable to cardiovascular
disease.
Methods
Literature search strategy
Thorough electronic searches were performed in January
2019 using MEDLINE (Ovid SP), Scopus, CCRT,
CINAHL, and PubMed. To achieve the maximum
sensitivity of the search strategy, the following combined
terms were used: “Dwarfism or Achondroplasia or Receptor,
Fibroblast Growth Factor, Type 3, or achondroplast”,
“Limb deformities, congenital, or osteochondrodysplasias,
or cartilage, or skeletal dysplasia”, “rhizomelic or
chondrodysplasia”, “cardiac catheterization”, “cardiac
catheterization or cardiac surgical procedures or cardiac”,
“heart atria or heart valves or heart ventricles”, “aorta or
aortic aneurysm”, “coronary vessel anomalies”, “dwarf”,
The reference lists of all eligible studies were reviewed
for further identification of potentially relevant studies
and assessed using the inclusion and exclusion criteria. A
PRISMA flow diagram depicting the overall search strategy
is provided in Figure 1.
Selection criteria
Eligible articles for the present systematic review included
case reports/series that focused on patients undergoing
cardiac intervention with dwarfism. Patients less than
16 years of age were excluded. Reports not published in
the English language, abstracts, conference presentations,
editorials, reviews and expert opinions were also excluded.
Of the 5,274 articles identified, 14 articles met inclusion
criteria consisting of 14 patients. Patient-level data were
extracted and analyzed.
Data extraction and critical appraisal
Data were extracted from article texts, tables, and figures
(AS, JC). Discrepancies between the reviewers were
resolved by discussion and consensus. When data were not
available, attempts were made to contact the corresponding
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Identification

1000

Studies identified by search of MEDLINE, Scopus, CCRT,
CINAHL, and PubMed
(n=5,274)

Records after duplicates removed

Eligibility

Screening

(n=3,847)

Records screened

Records excluded

(n=3,847)

(n=3,831)

Full-text articles assessed for eligibility

Full-text articles excluded, with reasons

(n=16)

(n=2)

Studies included in qualitative synthesis

Included

(n=14)

Studies included in quantitative
synthesis (meta-analysis)
(n=14)

Figure 1 PRISMA schematic diagram of the search strategy. PRISMA, Preferred Reporting Items for Systematic Reviews and MetaAnalysis.

authors to obtain the relevant data for the current study.
Statistical analysis
Baseline characteristics and demographics were reported
using descriptive statistics, including medians and
interquartile ranges (IQR) for continuous data and
percentages for categorical data.
Evaluation of missing data
Given the nature of this systematic review with data
obtained from individual case reports, not all articles shared
the same variables. This discrepancy was evaluated in terms
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of treatment of missing data and according adjustment
of the denominator determining percentage values.
Missing data in the routine variables such as demographic
variables were treated as missing at random, while variables
representing major adverse events were assumed to not have
occurred if not reported.
Results
Study characteristics
Overall, 5,274 articles were identified in the literature
search. Following application of the selection criteria,
a total of 14 case reports consisting of 14 patients were
included in the analysis. A manual search of references was
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Table 1 Patient demographics
Variable

Total (n=14)

Patient characteristics
Age, median [IQR]

55.5 [43.8, 59.8]

Male, % (n/N)

57.1 (8/14)

Height (cm), median [IQR]

102.0 [98.8, 112.5]

Weight (kg), median [IQR]

40.5 [29.5, 45.6]

2

BSA (m ), median [IQR]
2

BMI (kg/m ), median [IQR]

1.1 [0.9, 1.2]
32.1 [27.0, 45.9]

No family history of achondroplasia, %
(n/N)

35.7 (5/14)

Skeletal abnormalities
Scoliosis, % (n/N)

66.7 (6/9)

Kyphosis, % (n/N)

66.7 (6/9)

Lordosis, % (n/N)

11.1 (1/9)

Pectus carinatum, % (n/N)

11.1 (1/9)

Spinal stenosis, % (n/N)

11.1 (1/9)

Medical history
Hypertension, % (n/N)

55.6 (5/9)

Hypercholesterolemia, % (n/N)

55.6 (5/9)

Type 2 diabetes, % (n/N)

22.2 (2/9)

Coronary artery disease, % (n/N)

53.8 (7/13)

History of MI, % (n/N)

30.8 (4/13)

Smoking history, % (n/N)

50.0 (4/8)

History of transient ischemic attack, %
(n/N)

7.1 (1/14)

Obstructive sleep apnea, % (n/N)

7.1 (1/14)

BSA, body surface area; BMI, body mass index; MI, myocardial
infarction; IQR, interquartile range.

performed and did not reveal any additional studies.
Baseline characteristics
Median patient age was 55.5 [IQR, 43.8, 59.8] years,
median height was 102.0 [98.8, 112.5] cm, median BMI was
32.1 [27.0, 45.9], and 57.1% (8/14) were male. Of these
14 patients, nine had the following documented skeletal
abnormalities: 66.7% (6/9) had scoliosis, 66.7% (6/9) had
kyphosis, 11.1% (1/9) had lordosis, 11.1% (1/9) pectus
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carinatum or 11.1% (1/9) spinal stenosis. With respect to
comorbidities placing patients at risk for coronary events,
53.8% (7/13) had coronary artery disease, 55.6% (5/9)
had hypertension, 55.6% (5/9) hypercholesterolemia, and
50.0% (4/8) had a smoking history. 30.8% (4/13) patients
previously suffered a myocardial infarction. Details on
baseline characteristics are outlined in Table 1.
Pre-operative characteristics
Pre-operatively, the median left ventricular ejection fraction
was 50% [40, 60]. Coronary artery disease was present in
53.8% (7/13) of patients. Right coronary artery stenosis
was present in 75.0% (6/8) of patients. This was followed
by 71.4% (5/7) of patients with left anterior descending
stenosis, 57.1% (4/7) of patients with circumflex stenosis.
In total 50.0% (3/6) patients presented with ST segment
elevation. With respect to those with valvular disease,
21.4% (3/14) had aortic stenosis. Of these patients, the
median maximum aortic valve transvalvular gradient
was 114.5 [99.8, 129.2] mmHg. Additional preoperative
characteristics are demonstrated in Table 2.
Operative variables
We examined the patient population who underwent two
different sets of interventions: surgery and percutaneous
intervention. Of these, 57.1% (8/14) patients underwent
surgery and 42.9% (6/14) underwent percutaneous
intervention. Within the surgery group, 37.5% (3/8)
underwent multivessel coronary artery bypass grafting,
37.5% (3/8) underwent aortic valve replacement, one of
which was during a concomitant Type A aortic dissection
repair, 25.0% (2/8) underwent type A aortic dissection
repair, and the remaining 12.5% (1/8) underwent
pulmonary thromboendarterectomy. Of the percutaneous
group, 66.7% (4/6) underwent percutaneous coronary
intervention, 16.7% (1/6) underwent balloon aortic
valvuloplasty and balloon pulmonary valvuloplasty, and
16.7% (1/6) underwent micra transcatheter pacing system
implantation.
Of the patients who had surgery performed, 100.0%
(8/8) underwent cardiopulmonary bypass (CPB) with a
median aortic cross clamp time of 91.0 [67.5, 96.5] minutes
and a total cardiopulmonary bypass time of 136.5 [110.0,
178.8] minutes. Arterial cannula size was 20.0 [20.0, 24.0]
Fr. Bicaval cannulation was performed in all cases (5/5).
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(14/14) were asymptomatic relative to coronary symptoms
at the time of discharge with a median follow up time of
6.0 [6.0, 10.5] months and continued to be asymptomatic
at follow up (10/10). None of the cases reported mortality
with a median follow up time of 6.0 [6.0, 10.5] months.
Additional information regarding postoperative outcomes
and complications can be found in Tables 4 and 5.

Table 2 Preoperative characteristics
Variable

Total (n=14)

Ejection fraction % (n/N), median [IQR]

50 [40, 60]

Coronary artery disease

53.8 (7/13)

Right coronary artery stenosis, % (n/N)

75.0 (6/8)

Left anterior descending stenosis, % (n/N)

71.4 (5/7)

Circumflex stenosis, % (n/N)

57.1 (4/7)

ST elevation, % (n/N)

50.0 (3/6)

Discussion

Aortic stenosis, % (n/N)

21.4 (3/14)

Achondroplastic dwarfism represents a clinical challenge
for surgeons and clinicians given differences in anatomy
and physiology. Given a relatively similar lifespan
as the general population and a propensity for early
cardiovascular disease, it is not uncommon for these
patients to develop long-term health problems and require
cardiac intervention. The risk of heart disease is twice as
high in achondroplastic dwarfs compared to the general
population and three times as high when comparing male
achondroplastic dwarfs with the general population (4).
With studies noting increased cardiovascular risk in patients
with achondroplasia, it stands to reason that these patients
will require intervention in the future. These patients
require special procedural considerations with respect to
anesthesia, operative technique, and postoperative care.
These considerations have been evaluated previously with
respect to other operations, but cardiac interventions have
not been previously examined on a scale larger than case
reports. Our data demonstrated excellent survival, minimal
complications, and excellent secondary outcomes. It should
be noted the inherent bias in obtaining this data from
individual case reports which is noted in our limitations
discussion.
With respect to achondroplastic dwarfs, considerations
had to be made to adjust procedures to differences in patient
anatomy and physiology. From an anesthesia perspective,
the kyphotic cervical spine, maxillary hypoplasia and
megalencephaly can present difficult airway challenges in
patients with dwarfism (6). In the case reports that detailed
the intubation process, all three cases used a method of
video-assisted intubation. Anesthetic literature has also
suggested using smaller endotracheal tubes basing the size
on the weight of the patient (6). In our patient cohort,
35.7% (5/14) patients required pediatric endotracheal
tubes. The remaining nine case reports did not specify the
type or size of the endotracheal tube. Following intubation,
intravascular access and patient positioning are both
challenging due to short limbs, reduced joint mobility, and

Hypertrophic interventricular septum

66.7 (2/3)

Interventricular septum size (mm), median [IQR] 14.0 [13.5, 14.5]
Left ventricular hypertrophy, % (n/N)

33.3 (1/3)

Maximum aortic valve transvalvular gradient
(mmHg), median [IQR]

114.5 [99.8,
129.2]

Aortic valve area (cm2), median [IQR]

0.5 [0.5, 0.5]

Pulmonary stenosis, % (n/N)
Mean pulmonary artery pressure (mmHg),
median [IQR]
Preoperative atrial fibrillation, % (n/N)

7.1 (1/14)
45.0 [39.0, 51.5]
7.1 (1/14)

IQR, interquartile range.

Superior vena cava cannula size was 28.0 [28.0, 28.0] Fr with
a maximum size of 30 Fr, and inferior vena cava cannula
size was 28.0 [28.0, 28.0] Fr with a maximum size of 30 Fr.
With respect to aortic valve replacement, the sizes of the
implanted valve prostheses were 16 mm [14], 20 mm [15],
and 23 mm [9], respectively. The median aortic root size
was 11.0 [10.5, 31.5] mm with 33.3% (1/3) of patients
undergoing aortic root enlargement. In this patient,
root enlargement was accomplished by extending the
incision through the noncoronary Sinus of Valsalva along
the subaortic space and patching it with autologous
pericardium (9). Further operative details can be found in
Table 3.
Outcomes and complications
Post-operatively, patients spent a median of 2 [1, 5] days in
the intensive care unit with a median hospital length of stay
of 7 [5, 15] days. The postoperative aortic valve gradient
was 11.0 [9.5, 13.5] mmHg. One patient was centrally
cannulated for veno-arterial extracorporeal life support
following pulmonary artery endarterectomy. All patients
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Table 3 Intraoperative characteristics

Table 3 (continued)

Variable

Total (n=14)

Surgery, % (n/N)

57.1 (8/14)

Multivessel CABG, % (n/N)

37.5 (3/8)

Aortic valve replacement, % (n/N)

37.5 (3/8)

Type A aortic dissection repair, % (n/N)

25.0 (2/8)

Pulmonary thromboendarterectomy, %
(n/N)

12.5 (1/8)

Percutaneous intervention, % (n/N)

42.9 (6/14)

Percutaneous coronary intervention, %
(n/N)

66.7 (4/6)

Balloon aortic valvuloplasty and balloon
pulmonary valvuloplasty, % (n/N)

16.7 (1/6)

Micra transcatheter pacing system
implantation, % (n/N)

16.7 (1/6)

Fiberoptic scope, % (n/N)

33.3 (1/3)

Glidescope, % (n/N)

33.3 (1/3)

Video laryngoscopy, % (n/N)

33.3 (1/3)

Pediatric endotracheal tube, % (n/N)

35.7 (5/14)

Cardiopulmonary bypass, % (n/N)

100.0 (8/8)

Temperature
Normothermia (>34 ℃), % (n/N)

25.0 (2/8)

Mild hypothermia (28.1–34 ℃), % (n/N)

12.5 (1/8)

Moderate hypothermia (20.1–28 ℃), %
(n/N)

12.5 (1/8)

Deep hypothermia (14.1–20 ℃), % (n/N)

25.0 (2/8)

CPB time (minutes), median [IQR]

40.0 [29.5, 50.5]

Total (n=14)

Coronary artery bypass grafting
Vein harvested
Left saphenous, % (n/N)

33.3 (1/3)

Right and left saphenous, % (n/N)

33.3 (1/3)

Right saphenous, % (n/N)

33.3 (1/3)

Vein quality
Normal, % (n/N)

66.7 (2/3)

Moderate, % (n/N)

33.3 (1/3)

Artery harvested
LIMA, % (n/N)

66.7 (2/3)

LIMA and RIMA, % (n/N)

33.3 (1/3)

Normal, % (n/N)

100.0 (2/2)

Aortic valve replacement
Aortic cross clamp time (minutes),
median [IQR]

91.0 [67.5, 96.5]

Prosthetic valve type
Carbomedics, % (n/N)

33.3 (1/3)

Mechanical, bileaflet, % (n/N)

33.3 (1/3)

Perceval S aortic valve, % (n/N)

33.3 (1/3)

Aortic root size (mm), median [IQR]
Aortic root enlargement, % (n/N)

11.0 [10.5, 31.5]
33.3 (1/3)

CABG, coronary artery bypass grafting; circ, circulation; CPB,
cardio-pulmonary bypass; LIMA, left internal mammary artery;
RIMA, right internal mammary artery; IQR, interquartile range.

136.5 [110.0, 178.8]

Arterial cannulation site
Aorta, % (n/N)

60.0 (3/5)

Axillary, % (n/N)

20.0 (1/5)

Femoral, % (n/N)

20.0 (1/5)

Arterial cannula size (Fr), median [IQR]

Variable

Artery quality

Intubation method

Circ arrest time (minutes), median [IQR]

1003

20.0 [20.0, 24.0]

Bicaval cannulation

100.0 (5/5)

Superior vena cava cannula size (Fr),
median [IQR]

28.0 [28.0, 28.0]

Inferior vena cava cannula size (Fr),
median [IQR]

28.0 [28.0, 30.0]

Table 3 (continued)
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anatomy of the chest (8). Several reports note the use of
ultrasound guidance for intravascular access and arterial and
vein cut-downs for safe vascular exposure (10,11). These
differences from the general population must be considered
in preparing for procedures on patients with achondroplasia.
With respect to cardiac surgery interventions in these
patients, several operative techniques should be adjusted
or considered prior to and during the case. For procedures
requiring CPB, smaller cannula sizes were used in general.
It should be noted that all five cases where cannulation was
documented reported bicaval cannulation. This was likely
performed due to crowding from relatively large organs in a
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Table 4 Postoperative characteristics
Variable

Total (n=14)

Time in ICU (days), median [IQR]

2 [1, 5]

Number of postoperative days in hospital, median
[IQR]

7 [5, 15]

Postoperative aortic valve gradient (mmHg),
median [IQR]

11.0 [8.5, 13.5]

Postoperative complications
VA ECMO, % (n/N)

7.1 (1/14)

Mediastinal bleeding, % (n/N)

7.1 (1/14)*

Pleural effusion, % (n/N)

7.1 (1/14)*

Pneumothorax, % (n/N)

7.1 (1/14)*

Pulmonary embolism, % (n/N)

7.1 (1/14)*

Atrial fibrillation, % (n/N)

7.1 (1/14)

*, same patient who had undergone coronary artery bypass
grafting. ICU, intensive care unit; IQR, interquartile range; VA
ECMO, veno-arterial extracorporeal membrane oxygenation.

Table 5 Outcomes
Variable

Total (n=14)

Asymptomatic at discharge, % (n/N)

100.0 (14/14)

Follow up time (months), median [IQR]

6.0 [6.0, 10.5]

Asymptomatic at last follow up, % (n/N)

100.0 (10/10)

30-day mortality, % (n/N)

0.0 (0/14)

Overall mortality, % (n/N)

0.0 (0/14)

IQR, interquartile range.

smaller chest cavity. One report noted that surgeons should
assess patients for the largest possible cannulation sizes for
CPB to eliminate the possibility of reduced flow that may
compromise end-organ perfusion (11). For procedures
requiring artery or vein conduit, it should be noted that
saphenous vein graft may be challenging to obtain, too short
for purposes of a bypass, or unsuitable for bypass. One such
report noted smaller length of saphenous vein harvest with
moderate quality due to patient anatomy and performed
a three-vessel coronary-artery bypass with both right and
left internal mammary arteries (10). Another report noted a
29 cm saphenectomy incision that extended to the patient’s
ankle (12), and a third noted pre-operative phlebography to
assess for vein quality (13). A third report noted unsuitable
grafts given the severe musculoskeletal changes (14). Once
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median sternotomy was performed, reports noted concerns
regarding organ crowding with respect to the patient’s
chest anatomy, but found chest and organ size consistent
with the general population (10,11). However, due to some
thinning of the sternum, one such report noted closure
with absorbable suture in lieu of stainless steel wire (9).
With respect to aortic valve replacement, our investigation
noted the placement of valves required surgical aortic root
enlargement in one case (9) with aortic root dilation in
another case (15). These technical considerations must be
considered prior to performing any cardiac intervention on
patients with achondroplasia.
Aortic procedures in these patients also have unique
considerations. Two patients presented with type A
dissection and underwent subsequent hemiarch repairs. Due
to the small caliber of their major vessels, the feasibility of
cerebral perfusion was initially in question. However, the
authors did not encounter any difficulty with antegrade
selective cerebral perfusion in these patients. One patient
underwent central arterial and venous cannulation, while
another patient underwent peripheral arterial cannulation
but central venous cannulation.
With respect to percutaneous interventions in patients
with achondroplasia, our systematic review of available
interventions in this population demonstrates safe and
effective use of these techniques to alleviate and treat
cardiovascular conditions in these patients. Studies have
noted technical difficulties with endovascular access of the
coronary arteries using the transradial approach due to short
limbs, elbow angles and kyphoscoliosis (16,17). Obtaining
arterial access has also been noted to be challenging with
respect to accessing the femoral vessels, and one study
noted ultrasonographic assistance was required (14).
Determination of radial versus femoral access should be
determined on a case-by-case basis with the two reports of
radial access noting their choice was based on complexity
of intervention required (17,18). Further studies are
necessary to elucidate the benefits and disadvantages of each
technique. Although obtaining coronary access was difficult,
no challenges with respect to coronary morphology were
encountered. In total these six reports noted success at
achieving revascularization or elimination of stenosis with
minimal complication.
Evaluation of both surgical and percutaneous techniques
revealed several suggestions by each of these case reports.
Unfortunately, due to the number of cases in total, these
recommendations are areas that require further study.
For surgical intervention, these case reports suggest the
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following: videoscopic intubation with smaller endotracheal
tubes, obtain intravascular access using ultrasonography
and arterial cutdown where necessary, use the largest
available cannula size that vessels can accommodate with
pediatric sized cannulas available, perform preoperative
phlebography of saphenous veins if being used as conduits,
and if aortic valve replacement is required, consider aortic
root enlargement or dilation for appropriate fitting of
the replacement valve. With respect to percutaneous
intervention, clinicians should be aware of the challenges of
coronary vessel cannulation and the relative advantages and
disadvantages of radial versus femoral access with respect to
patient anatomy using ultrasonography when able for vessel
access.
This systematic review has demonstrated performing
surgical and percutaneous interventions in dwarfs is both
safe and effective though further study is needed to ensure
this is not due to a selective publishing of favorable cases.
Operative and procedural considerations must be made
to ensure success though these can be accomplished
with expert care and preoperative planning. Further, a
prospective registry would be beneficial to determine
best practices. Given the pre-operative concerns of organ
size and crowding shared by the articles included in
this systematic review, it is possible that this sentiment
is shared by other cardiac surgeons. This predicted
challenge represents a barrier that may make surgeons
hesitant to operate on achondroplastic dwarfs and decline
surgical intervention for those who may benefit from an
intervention. A prospective registry would further support
the findings of this systematic review and help to eliminate
operative concerns surgeons may have with respect to
this population’s anatomy. This systematic review of
the available literature suggests these procedures can be
accomplished safely and effectively.
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Limitations and future directions
Achondroplasia represents a relatively rare condition and
therefore this systematic review encapsulates the minority
of this small subgroup of patients undergoing cardiac
interventions. Given this, most of the data in this systematic
review comes from individual case reports, which are
subject to a publication bias. Successful cases are more
likely to be reported which is especially true here as these
reports show excellent survival and low complication rates.
Ideally, a prospective registry would follow patients with
the necessary pre-operative characteristics following their
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intervention. However, a prospective database here is likely
to suffer from a lower power given our current literature
search only produced 14 of this particular type of patient.
Our results with respect to survival and complications
should be viewed with the understanding that the cases
where patients did not survive may not be reported and
therefore our survival is likely overestimated and our
complications underestimated.
Conclusions
Common cardiac procedures can be performed with
reasonable safety in patients with achondroplasia. Operative
and procedural adjustments may need to be made with
respect to equipment and technique to accommodate
patient-specific needs.
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